Literature DB >> 16253378

TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.

S El-Andaloussi1, H Johansson, A Magnusdottir, P Järver, P Lundberg, Ulo Langel.   

Abstract

One approach to investigate gene function, by silencing the activity of certain proteins, is the usage of double stranded decoy oligodeoxynucleotides (ds decoy ODNs). Decoy, in this sense, is ds ODNs bearing the consensus binding sequence for a DNA-binding protein. This can be used in clinical settings to attenuate the effect of overexpressed transcription factors in tumor cells. We here choose to target the oncogenic protein Myc. Since oligonucleotides are poorly internalized to cells, a cell-penetrating peptide, TP10, was coupled to the Myc decoy, using two different strategies. Either TP10 was simply mixed with ds decoy ODNs forming complexes through non-covalent electrostatic interactions, or by having a nona-nucleotide overhang in one of the decoy strands, and adding a complementary PNA sequence coupled to an NLS sequence and TP10, which could hybridize to the Myc decoy. By using these strategies, uptake was significantly enhanced, especially with the co-incubation approach. Interestingly, various endocytosis inhibitors had no effect on the uptake pattern, suggesting that uptake of these complexes is not mediated via endocytosis. Finally, a decreased proliferative capacity was observed when treating the neuroblastoma cell line N2a with TP10-PNA conjugate hybridized to Myc decoy compared to naked Myc decoy and untreated cells. A dose-dependent decrease in proliferation was also observed in MCF-7 cells, when using both strategies. These results suggest an alternative way to efficiently deliver ds ODNs into cells using the cell-penetrating peptide TP10 and prevent tumor growth by targeting the oncogenic protein Myc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253378     DOI: 10.1016/j.jconrel.2005.09.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  19 in total

Review 1.  Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.

Authors:  Seyed Mohammad Ali Hosseini Rad; Lida Langroudi; Fatemeh Kouhkan; Laleh Yazdani; Alireza Nouri Koupaee; Sara Asgharpour; Zahra Shojaei; Taravat Bamdad; Ehsan Arefian
Journal:  Tumour Biol       Date:  2015-04-04

2.  Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction.

Authors:  Helin Räägel; Margot Hein; Asko Kriiska; Pille Säälik; Anders Florén; Ülo Langel; Margus Pooga
Journal:  Cell Mol Life Sci       Date:  2013-07-13       Impact factor: 9.261

3.  Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells.

Authors:  Zifan Gong; Mackenzie T Walls; Alisha N Karley; Amy J Karlsson
Journal:  Mol Biotechnol       Date:  2016-12       Impact factor: 2.695

Review 4.  Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Youngro Byun; Allan E David; Huining He; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2013-07-30       Impact factor: 4.396

Review 5.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

6.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

Review 7.  Action of antimicrobial peptides and cell-penetrating peptides on membrane potential revealed by the single GUV method.

Authors:  Md Mizanur Rahman Moghal; Farzana Hossain; Masahito Yamazaki
Journal:  Biophys Rev       Date:  2020-03-09

8.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 9.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines.

Authors:  H Dan Lewis; Ali Husain; Robert J Donnelly; Dimitrios Barlos; Sheraz Riaz; Kalyani Ginjupalli; Adetola Shodeinde; Beverly E Barton
Journal:  BMC Biotechnol       Date:  2010-10-28       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.